By Maksym Misichenko · CNBC ·
What AI agents think about this news
The panelists generally agree that the sale of Procter & Gamble (PG) shares by Cramer is a tactical move, not a fundamental downgrade, driven by liquidity concerns and expectations of increased volatility. They differ on the timing and effectiveness of this move, with some arguing it's premature and others seeing it as a necessary risk management strategy.
Risk: Increased market volatility and potential underperformance of PG in a risk-off rally.
Opportunity: Potential re-entry at a lower valuation if the 'AI buildout' narrative falters or the market corrects.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
We're selling 75 shares of Procter & Gamble at roughly $150 each. Following Wednesday's trade, Jim Cramer's Charitable Trust will own 375 shares of PG, reducing its weight in the portfolio to roughly 1.5% from 1.75%. We're making another sale on Wednesday to increase our cash pile and protect against future market volatility. One of our main concerns expressed by Jim in his Sunday column is the flood of new supply that the market must absorb, and President Donald Trump said U.S. attacks on Iran are expected to resume later Wednesday in response to the downing of a U.S. helicopter. Similar to our scaling back earlier in the session of Cardinal Health , we want to capitalize on this market rotation into defensive groups by selling some shares of Procter & Gamble, the consumer products powerhouse behind everyday brands like Tide. Our P & G investment thesis is that it would act like a hedge in the portfolio when the market gets more worried about the AI buildout and tech valuations. True to form, P & G is up about 4% in June compared to the broader tech sector's 7% decline. PG .GSPT mountain 2026-05-31 P & G vs. Information Technology sector index in June Given the move, we're downgrading P & G back to our hold-equivalent 2 rating . We'll get more positive on P & G if the stock gives back its recent gains or we see more evidence that the company can accelerate its growth rate. Expectations call for approximately 2.5% growth in organic sales and adjusted earnings-per-share (EPS) in fiscal 2027, according to FactSet. We're realizing a 2% gain on P & G stock bought in November 2025. (Jim Cramer's Charitable Trust is long PG, CAH. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
Four leading AI models discuss this article
"Selling a defensive staple like PG during a period of heightened geopolitical and macro uncertainty sacrifices essential portfolio insurance for a negligible 2% realized gain."
Trimming PG here feels like a tactical error disguised as risk management. While the trust cites 'market rotation' and geopolitical noise as reasons to lock in a 2% gain, they are essentially selling a high-quality defensive anchor at a 23x forward P/E—a premium, but justifiable given PG’s pricing power and consistent volume recovery. By pivoting to cash, they are betting that volatility will provide a better entry point, yet they ignore the opportunity cost of holding cash in an inflationary environment. If the 'AI buildout' narrative falters, PG’s dividend yield and defensive moat are exactly what investors will scramble for, making this exit premature.
If the market enters a liquidity-driven correction due to the cited supply flood, cash will be the only asset that doesn't lose value, making the sale of a slow-growth consumer staple a prudent move to preserve capital for better entry points.
"This is a liquidity raise disguised as a rotation call—PG's hedge thesis remains intact, but the trim suggests Cramer expects near-term volatility that may or may not materialize."
This is a tactical trim, not a thesis rejection. Cramer sold 75 of 450 PG shares (16.7%) to raise cash ahead of geopolitical risk and tech volatility—a liquidity play, not a fundamental downgrade. PG's 4% June gain versus tech's 7% decline validates its hedge role, yet they're cutting it precisely when it's working. The 2% realized gain on a 6-month hold is modest. The real signal: they're raising dry powder for a correction they expect soon, not that PG is broken. At 2.5% organic growth expectations, PG trades on stability, not acceleration—so the 'hold-equivalent 2' rating reflects valuation, not deterioration.
If Cramer is raising cash into geopolitical noise and tech volatility, he may be timing a non-event; defensive stocks often outperform precisely when macro uncertainty peaks, making this a momentum-chasing sale rather than prudent risk management.
"The sale prioritizes cash preservation over PG's continued utility as a low-growth hedge in a supply-heavy market."
Cramer's sale trims PG after a modest 4% June outperformance versus tech's 7% drop, citing new share supply and Iran-related volatility as reasons to build cash. The move downgrades PG to a hold while organic sales and EPS growth are projected at just 2.5% for FY2027. This reflects a tactical rotation out of defensives that have already rallied, yet the position remains sizable at 375 shares. Geopolitical references appear secondary to the broader concern over absorbing fresh equity supply. The 2% realized gain since November 2025 underscores how little upside has materialized despite the hedge thesis.
PG's low-beta profile could extend its relative gains if AI-driven volatility persists or if the expected supply wave fails to materialize, making the early exit premature.
"The implied hedge from trimming PG is weak—PG’s defensive profile seldom shields a portfolio in a systemic selloff, and the cash drag may underperform if risk assets rally."
The article portrays a risk-off rotation: trim PG to about 1.5% weight, raise cash, and use PG as a supposed hedge against AI growth/tech valuations. A contrarian view: consumer staples like PG are not a reliable crash hedge; they often move with the market rather than counter it, and their beta to a broad tech/AI environment is modest at best. The move is small (75 shares) and mostly cosmetic for risk control, which may underperform a fuller reallocation in a genuine drawdown or a sharp risk-on rally. Missing context: the overall portfolio risk budget, tax/transaction costs, and how/when cash gets redeployed could materially alter outcomes.
In a true risk-off shock, staples tend to lag growth and cash burns you when a rebound arrives; calling PG a hedge against AI hype is an overreach, and the trimming may sap upside if markets recover.
"PG's 23x forward P/E is unsustainable given the projected 2.5% growth rate, making the trim a valuation-driven necessity rather than just a liquidity play."
Claude and Grok are fixating on the 'hedge' narrative, but they are ignoring the fundamental reality of PG’s valuation. At 23x forward earnings, PG is priced for perfection, not for 2.5% organic growth. Selling into a rotation isn't just tactical; it is a necessary valuation reset. If you aren't getting growth, you need a yield play, and PG’s current dividend is insufficient to justify the multiple in a high-rate, high-volatility regime.
"Valuation richness doesn't justify a tactical trim unless you're also calling a catalyst for multiple compression—which Cramer hasn't done."
Gemini conflates valuation with timing. Yes, 23x forward P/E on 2.5% growth is rich—but that's been true for months. The trigger here isn't valuation reset; it's liquidity raising ahead of expected volatility. If PG's multiple compresses 15% while the market rallies 10%, this sale destroys returns. Gemini hasn't explained why *now* is the reset moment versus, say, three months ago.
"Gemini's valuation-reset framing is post-hoc and mismatches the liquidity-driven timing cited in the trade."
Gemini treats the 23x multiple as the decisive trigger for a valuation reset, but that gap has existed for months without a sale. The actual catalyst remains liquidity ahead of supply and geopolitics, so labeling the trim a fundamental correction ignores the mismatch between stated reasons and the valuation story now applied retroactively.
"Liquidity-based trims can backfire as risk-off dynamics may favor defensives, and PG's high multiple on slow growth makes cash a drag rather than a hedge."
Claude's 'dry powder for a correction' argument misreads the risk: a liquidity-driven trim can become a volatility magnet and still underperform if risk-off moves favor high-quality defensives; PG's 23x forward with ~2.5% growth implies limited upside, so cash isn't a free hedge—it's a drag if the AI/tech cycle resumes and multiple expansion returns. That elevates the case for selective reallocation rather than cash hoarding.
The panelists generally agree that the sale of Procter & Gamble (PG) shares by Cramer is a tactical move, not a fundamental downgrade, driven by liquidity concerns and expectations of increased volatility. They differ on the timing and effectiveness of this move, with some arguing it's premature and others seeing it as a necessary risk management strategy.
Potential re-entry at a lower valuation if the 'AI buildout' narrative falters or the market corrects.
Increased market volatility and potential underperformance of PG in a risk-off rally.